Main > ONCOLOGY (**) > Thyroid Cancer>Anaplastic>MET>*** > TREAT.: > Co: CH. N. Dabrafenib+Trametinib

---

Co: CH. N. Dabrafenib+Trametinib's subsections
(*) USA Approval Date: 2018. 05.04.
>with BRAF V600E Mutation
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2018. 10.30.
PR Web-Site
TradeMark

Co: CH. N. Dabrafenib+Trametinib's products
This section has no products